BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25839093)

  • 1. Distribution of the cytoskeletal protein, Nestin, in acute leukemia.
    Du X; Yang XH; Wu YF; Liang J; Zhang J; Huang ZC; Zhu ZP; Lin W; Zou MX; Wen JY; Wu SJ; Guo R; Zhang XM; Lahn BT; He F; Xiang AP
    Biotech Histochem; 2015 Jul; 90(5):384-94. PubMed ID: 25839093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of PIM-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival.
    Kapelko-Słowik K; Urbaniak-Kujda D; Wołowiec D; Jaźwiec B; Dybko J; Jakubaszko J; Słowik M; Kuliczkowski K
    Postepy Hig Med Dosw (Online); 2013 Jun; 67():553-9. PubMed ID: 23752607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute lymphoblastic leukemia following preleukemic syndromes in adults.
    Escudier SM; Albitar M; Robertson LE; Andreeff M; Pierce S; Kantarjian HM
    Leukemia; 1996 Mar; 10(3):473-7. PubMed ID: 8642864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of some cytochemical activities to the expression of CD34 marker in acute leukemia.
    Klobusická M; Babusíková O; Hrivnáková A
    Neoplasma; 1993; 40(5):309-14. PubMed ID: 7505888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method comparison study of flow cytometry and cytomorphology to determine the percentages of blasts in patients with acute leukemia after induction and consolidation chemotherapy.
    Wongprajun S; Auewarakul CU
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S157-64. PubMed ID: 20364570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow necrosis in acute leukemia: Clinical characteristic and outcome.
    Badar T; Shetty A; Bueso-Ramos C; Cortes J; Konopleva M; Borthakur G; Pierce S; Huang X; Chen HC; Kadia T; Daver N; Dinardo C; O'Brien S; Garcia-Manero G; Kantarjian H; Ravandi F
    Am J Hematol; 2015 Sep; 90(9):769-73. PubMed ID: 26017166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia.
    Ludescher C; Eisterer W; Hilbe W; Gotwald M; Hofmann J; Zabernigg A; Cianfriglia M; Thaler J
    Leukemia; 1995 Feb; 9(2):350-6. PubMed ID: 7869774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytomorphology of acute mixed leukemia].
    Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
    Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia.
    Ouyang G; Xu Z; Jiang D; Zhu H; Wang Y; Wu W; Sun Y; Sheng L; Xu K; Lou Y; Mu Q; Zhang Y; Wu N; Cheng J; Duan S
    J Int Med Res; 2019 Apr; 47(4):1483-1492. PubMed ID: 30614357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of VLA molecules on acute leukemia cells: relationship with disease characteristics.
    Vila L; Thomas X; Campos L; Sabido O; Archimbaud E
    Exp Hematol; 1995 Jun; 23(6):514-8. PubMed ID: 7768307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the immunoglobulin superfamily cell membrane adhesion molecule Cd146 in acute leukemia.
    Cavazzini F; Campioni D; Ferrari L; Buldini B; Bardi MA; Michielotto B; Lazzari MC; Ongari M; Dabusti M; Daghia G; Sofritti O; Basso G; Lanza F; Cuneo A
    Cytometry B Clin Cytom; 2016 May; 90(3):247-56. PubMed ID: 26102234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of nucleolar organizer regions in human leukemic cells.
    Grotto HZ; Metze K; Lorand-Metze I
    Anal Cell Pathol; 1993 Jul; 5(4):203-12. PubMed ID: 8363982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia.
    Porwit-MacDonald A; Ivory K; Wilkinson S; Wheatley K; Wong L; Janossy G
    Leukemia; 1995 Jul; 9(7):1191-8. PubMed ID: 7543174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease.
    Drach J; Drach D; Glassl H; Gattringer C; Huber H
    Cytometry; 1992; 13(8):893-901. PubMed ID: 1459006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte colony-stimulating factor receptors on human acute leukemia: biphenotypic leukemic cells possess granulocyte colony-stimulating factor receptors.
    Shimoda K; Okamura S; Harada N; Ikematsu W; Kondo S; Kawasaki C; Tanaka T; Etou T; Akashi K; Okamura T
    Cancer Res; 1992 Jun; 52(11):3052-5. PubMed ID: 1534271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of PRAME gene in acute leukemia and its clinical significance].
    Zhu YL; Liu J; Zhu P; DU JW; Zhang Y; Gu JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1144-9. PubMed ID: 18088454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia.
    Boos J; Hohenlöchter B; Schulze-Westhoff P; Schiller M; Zimmermann M; Creutzig U; Ritter J; Jurgens H
    Med Pediatr Oncol; 1996 Jun; 26(6):397-404. PubMed ID: 8614376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of the TNF-α receptors, TNFRSF2 and TNFRSF9, on cell migration molecules Fascin-1 and Versican in acute leukemia.
    El Kramani N; Elsherbiny NM; El-Gayar AM; Ebrahim MA; Al-Gayyar MMH
    Cytokine; 2018 Nov; 111():523-529. PubMed ID: 29861382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transient abnormal myelopoiesis followed by acute leukemia in children with Down syndrome].
    Hatae Y; Takeda T; Nakadate H; Hatayama Y; Kishino T; Ogawa Y
    Rinsho Ketsueki; 1990 Dec; 31(12):1939-44. PubMed ID: 2150419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of acute leukemia cells to the cytotoxic activity of allogeneic and autologous lymphokine activated killer (LAK) effectors: correlation with the rate and duration of complete remission and with survival.
    Lauria F; Raspadori D; Rondelli D; Ventura MA; Foà R
    Leukemia; 1994 May; 8(5):724-8. PubMed ID: 8182932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.